Global Medical Oncology Director: Strategic Leader

Bristol-Myers Squibb Co; Toms River (NJ); Hybrid; USD 255,000 - 308,000; Full time

Benefits offered by this job

Flexible Time Off

Paid holidays

Wellbeing programs

Retirement plan

Job summary

Bristol Myers Squibb is seeking an innovative Medical Product Lead, Global Medical Oncology, focused on Izabren (BMS-986507). You will drive a unified global medical strategy, lead international teams, and accelerate evidence generation across breast, lung, GI, and GU cancers.

Reporting to the Worldwide Medical Affairs leadership, this role anchors medical engagement during pre-launch and potential launch phases.

Qualifications

• Advanced degree in medicine, science, or related field (MD, PhD, PharmD; MD preferred).
• 15+ years of medical affairs, development, or commercial experience, with a strong track record in international markets.
• Pharmaceutical experience in solid tumors; ADCs, bispecific antibodies and/or Phase 3 oncology development preferred.
• Proven ability to lead large, geographically distributed teams and manage matrix environments.
• Deep regulatory and healthcare knowledge across international markets.

Responsibilities

• Develop and execute a unified global medical strategy for Izabren across tumor types and lines of therapy.
• Lead and manage the Izabren medical teams at Global and US levels, aligning messaging, evidence, and education.
• Oversee trial execution, site engagement, and KPI dashboards to maximize program impact.
• Engage with investigators, KOLs, and professional societies; plan data dissemination at key congresses.

Skills

Global leadership

Oncology expertise

Cross-functional leadership

Regulatory knowledge

Medical strategy

Education

MD/PhD/PharmD

Job description

Bristol Myers Squibb is seeking an innovative Medical Product Lead, Global Medical Oncology, focused on Izabren (BMS-986507). You will drive a unified global medical strategy, lead international teams, and accelerate evidence generation across breast, lung, GI, and GU cancers.

Reporting to the Worldwide Medical Affairs leadership, this role anchors medical engagement during pre-launch and potential launch phases.